InnovHeart develops Transcatheter Mitral Valve Replacement systems.
InnovHeart has raised €49M across 2 funding rounds from 4 investors. Based in Milan, Italy; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| — | Other | — |
| — |
| View deal → |
| 2022-01-28 | Series C | €49M | Genextra,Grand Pharma,Indaco Venture Partners,Panakès Partners | View deal → |
